Lenident (Procaine Hydrochloride)

Lenident, a dental local anesthetic, acts on peripheral nerves to provide temporary loss of sensation during oral procedures.

• Dental extractions: enables painless removal of teeth by blocking nerve transmission.
• Periodontal surgery: provides anesthesia for gum tissue manipulation.
• Topical oral procedures: numbs the oral mucosa for minor interventions such as scaling or biopsy.
• Root canal therapy: facilitates pain‑free instrumentation of the root canal system.
• Dental implant placement: offers local anesthesia during osteotomy and implant insertion.

• Procaine Hydrochloride exerts its anesthetic effect by reversibly binding to voltage‑gated sodium channels on neuronal membranes. This blockade prevents the influx of sodium ions during depolarisation, thereby inhibiting the generation and propagation of nerve impulses. The result is a rapid, localized loss of sensation in the area where the drug is applied, with onset typically within minutes and duration of effect lasting from several minutes to an hour, depending on dose and site.

Adverse reactions to Lenident are generally related to its local anaesthetic properties and occasional hypersensitivity.

Common Side Effects

• Mild burning or stinging at the application site
• Transient redness or swelling of the mucosa
• Light‑headedness or dizziness
• Nausea

Serious or Rare Side Effects

• Allergic reaction including rash, itching, or swelling
• Anaphylaxis, a severe, potentially life‑threatening hypersensitivity
• Methemoglobinemia, characterized by reduced oxygen‑carrying capacity of blood
• Cardiac arrhythmias or seizures in cases of systemic absorption

When using Lenident, clinicians should observe several precautionary measures to minimise risk.

• Allergy assessment: verify the patient has no known hypersensitivity to procaine or related ester‑type anesthetics.
• Cardiovascular monitoring: use caution in patients with significant heart disease, as systemic absorption may affect cardiac conduction.
• Dosage limitation: adhere to recommended maximum single‑dose limits to avoid toxic plasma concentrations.
• Concurrent medications: review concomitant drugs that may potentiate cardiac or CNS effects.
• Special populations: exercise care in patients with hepatic impairment, as metabolism may be reduced.
• Store at ambient temperature: keep in the original container, protect from light and moisture, and discard after the expiry date.

Lenident may interact with other medicines; awareness of these interactions helps ensure safe use.

Major Interactions (Avoid)

• MAO inhibitors: concurrent use can increase the risk of severe hypotension and cardiac effects.
• Class I antiarrhythmic agents (e.g., quinidine, procainamide): combined use may potentiate cardiotoxicity.
• High‑dose epinephrine: may enhance systemic toxicity of procaine.

Moderate Interactions (Monitor Closely)

• Anticoagulants (e.g., warfarin): local anesthetic infiltration may increase bleeding tendency.
• Beta‑blockers: may augment bradycardia or hypotensive responses.
• Central nervous system depressants (e.g., benzodiazepines, opioids): may increase sedation when systemic absorption occurs.